Evidence map›Paper›PMID 23594496›Full record

ArticleHuman heredity2012

Incorporating prior biologic information for high-dimensional rare variant association studies.

Melanie A Quintana, Fredrick R Schumacher, Graham Casey, Jonine L Bernstein, Li Li, David V Conti

Abstract read
In one paragraph

Article in Human heredity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melanie A QuintanaDepartment of Preventive Medicine, University of Southern California, Los Angeles, CA 90089, USA.
Fredrick R Schumacher
Graham Casey
Jonine L Bernstein
Li Li
David V Conti

Funding

University of Toronto Coordinating Genetics Core & Clinical Trial SiteU01DA020830 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI SWAN, GARY E · 2005 to 2014
$22.4M
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast CancerR01CA129639 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BERNSTEIN, JONINE L. · 2009 to 2013
$15.6M
Transdisciplinary Research on Energetics and CancerU54CA116867 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI BERGER, NATHAN A. · 2005 to 2010
$11.3M
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENEU01CA083178 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE LISA · 1999 to 2003
$9.3M
Interaction of Radiation, BRCA1/2, and Breast CancerR01CA097397 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE LISA · 2002 to 2006
$4.1M
Incorporating intermediate biomarkers of folate with colorectal cancerR01CA140561 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, DAVID V, SCHUMACHER, FREDRICK RAY · 2011 to 2015
$1.9M
Integrated variation detection annotation and analysis for high-throughout sequeR01HG006465 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WANG, KAI · 2012 to 2016
$1.8M
HIERARCHICAL MODELING OF INTERACTIONS IN GENOME-WIDE AND PATHWAY-BASED STUDIESR01ES016813 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, DAVID V · 2009 to 2010
$1.1M
Detecting GxE Interactions in Genome-wide Association StudiesR21HL115606 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GAUDERMAN, WILLIAM JAMES · 2012 to 2014
$481k
Genetic Epidemiology of Insulin Resistance Pathway Factors and Colon CancerK22CA120545 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LI, LI · 2006 to 2008
$468k
NCI NIH HHS K22 CA120545NCI NIH HHS R01 CA097397NCI NIH HHS R01 CA129639NCI NIH HHS R01 CA140561NCI NIH HHS R01CA14561NCI NIH HHS U01 CA083178NCI NIH HHS U54 CA116867NHGRI NIH HHS R01 HG006465NHLBI NIH HHS R21 HL115606NHLBI NIH HHS R21HL115606NIDA NIH HHS U01 DA020830NIEHS NIH HHS R01 ES016813
6 · The paper itself

Abstract

backgroundGiven the increasing scale of rare variant association studies, we introduce a method for high-dimensional studies that integrates multiple sources of data as well as allows for multiple region-specific risk indices.

methodsOur method builds upon the previous Bayesian risk index by integrating external biological variant-specific covariates to help guide the selection of associated variants and regions. Our extension also incorporates a second level of uncertainty as to which regions are associated with the outcome of interest.

resultsUsing a set of study-based simulations, we show that our approach leads to an increase in power to detect true associations in comparison to several commonly used alternatives. Additionally, the method provides multi-level inference at the pathway, region and variant levels.

conclusionTo demonstrate the flexibility of the method to incorporate various types of information and the applicability to high-dimensional data, we apply our method to a single region within a candidate gene study of second primary breast cancer and to multiple regions within a candidate pathway study of colon cancer.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationModels, StatisticalBayes TheoremBRCA1 ProteinBreast NeoplasmsColonic NeoplasmsComputer SimulationDNA RepairFemaleHumansModels, GeneticBRCA1 ProteinBRCA1 protein, human

Identifiers

PMID23594496
PMCPMC4058572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.